Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
inactivated influenza vaccine (12 trials)
influenza vaccine, recombinant hemagglutinin (1 trial)
adimrsc-2f (2 trials)
Influenza, Human (Phase 4)
Trials (14 total)
Trial APIs (3 total)